Septic

·MeSH: Sepsis

12 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
giapreza	LA JOLLA PHARMACEUTICAL CO (LJPC)
GIAPREZA	Innoviva, Inc. (INVA)
GIAPREZA®	Innoviva, Inc. (INVA)
norepinephrine bi	Amneal Pharmaceuticals, Inc. (AMRX)
quelimmune	SeaStar Medical Holding Corporation (ICU)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(1)

Drug	Company
Methylene Blue	ENANTA PHARMACEUTICALS INC (ENTA)

Preclinical(2)

Drug	Company
hemoglobin-based artificial oxygen carriers	SANGUI BIOTECH INTERNATIONAL INC (SGBI)
sbt102	SANGUI BIOTECH INTERNATIONAL INC (SGBI)

Unknown(1)

Drug	Company
SIUS Gamma	REPLIGEN CORP (RGEN)

Phase 4(2)

Drug	Company
chloroprocaine ophthalmic gel 3%	HARROW, INC. (IMMY)
fluorometholone acetate ophthalmic suspension 0.1%	HARROW, INC. (IMMY)

BioSniper tracks 12 drugs in development for Septic across 8 companies.

There are 1 clinical trial targeting Septic tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.